141 related articles for article (PubMed ID: 11103895)
1. The development and expression of locomotor sensitization to nicotine in the presence of ibogaine.
Zubaran C; Shoaib M; Stolerman IP
Behav Pharmacol; 2000 Aug; 11(5):431-6. PubMed ID: 11103895
[TBL] [Abstract][Full Text] [Related]
2. 18-Methoxycoronaridine acts in the medial habenula to attenuate behavioral and neurochemical sensitization to nicotine.
Eggan BL; McCallum SE
Behav Brain Res; 2016 Jul; 307():186-93. PubMed ID: 27059333
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment with the putative anti-addictive drug, ibogaine, increases the potency of cocaine to elicit locomotor responding: a study with acute and chronic cocaine-treated rats.
Szumlinski KK; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 1999 Jul; 145(2):227-33. PubMed ID: 10463325
[TBL] [Abstract][Full Text] [Related]
4. Ibogaine acts at the nicotinic acetylcholine receptor to inhibit catecholamine release.
Mah SJ; Tang Y; Liauw PE; Nagel JE; Schneider AS
Brain Res; 1998 Jun; 797(1):173-80. PubMed ID: 9630615
[TBL] [Abstract][Full Text] [Related]
5. Ibogaine-like effects of noribogaine in rats.
Glick SD; Pearl SM; Cai J; Maisonneuve IM
Brain Res; 1996 Mar; 713(1-2):294-7. PubMed ID: 8725004
[TBL] [Abstract][Full Text] [Related]
6. Mirtazapine attenuates the expression of nicotine-induced locomotor sensitization in rats.
Barbosa-Méndez S; Jurado N; Matus-Ortega M; Martiñon S; Heinze G; Salazar-Juárez A
Eur J Pharmacol; 2017 Oct; 812():28-37. PubMed ID: 28668504
[TBL] [Abstract][Full Text] [Related]
7. Ibogaine and the dopaminergic response to nicotine.
Maisonneuve IM; Mann GL; Deibel CR; Glick SD
Psychopharmacology (Berl); 1997 Feb; 129(3):249-56. PubMed ID: 9084063
[TBL] [Abstract][Full Text] [Related]
8. Does nicotine modify the psychotoxic effect of methamphetamine? Assessment in terms of locomotor sensitization in mice.
Kuribara H
J Toxicol Sci; 1999 Feb; 24(1):55-62. PubMed ID: 10073337
[TBL] [Abstract][Full Text] [Related]
9. [Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action].
Kazlauskas S; Kontrimaviciūte V; Sveikata A
Medicina (Kaunas); 2004; 40(3):216-9. PubMed ID: 15064541
[TBL] [Abstract][Full Text] [Related]
10. Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulation.
Pearl SM; Johnson DW; Glick SD
Psychopharmacology (Berl); 1995 Oct; 121(4):470-5. PubMed ID: 8619010
[TBL] [Abstract][Full Text] [Related]
11. Effects of cocaine, nicotine, dizocipline and alcohol on mice locomotor activity: cocaine-alcohol cross-sensitization involves upregulation of striatal dopamine transporter binding sites.
Itzhak Y; Martin JL
Brain Res; 1999 Feb; 818(2):204-11. PubMed ID: 10082805
[TBL] [Abstract][Full Text] [Related]
12. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
Liechti ME; Markou A
Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
[TBL] [Abstract][Full Text] [Related]
13. Cocaine + nicotine mixture enhances induction and expression of behavioral sensitization in rats.
Barbosa-Méndez S; Salazar-Juárez A
J Psychiatr Res; 2018 May; 100():88-98. PubMed ID: 29499475
[TBL] [Abstract][Full Text] [Related]
14. Calcium channel antagonists attenuate cross-sensitization to the rewarding and/or locomotor effects of nicotine, morphine and MK-801.
Biala G; Weglinska B
J Pharm Pharmacol; 2004 Aug; 56(8):1021-8. PubMed ID: 15285847
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration.
Glick SD; Maisonneuve IM; Kitchen BA; Fleck MW
Eur J Pharmacol; 2002 Mar; 438(1-2):99-105. PubMed ID: 11906717
[TBL] [Abstract][Full Text] [Related]
16. Ibogaine enhances the expression of locomotor sensitization in rats chronically treated with cocaine.
Szumlinski KK; Maisonneuve IM; Glick SD
Pharmacol Biochem Behav; 1999 Jul; 63(3):457-64. PubMed ID: 10418788
[TBL] [Abstract][Full Text] [Related]
17. Locomotor activity in rats after administration of nicotinic agonists intracerebrally.
Reavill C; Stolerman IP
Br J Pharmacol; 1990 Feb; 99(2):273-8. PubMed ID: 2328395
[TBL] [Abstract][Full Text] [Related]
18. Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat.
Panagis G; Nisell M; Nomikos GG; Chergui K; Svensson TH
Brain Res; 1996 Aug; 730(1-2):133-42. PubMed ID: 8883897
[TBL] [Abstract][Full Text] [Related]
19. Behavioural and biochemical adaptations to nicotine in rats: influence of MK801, an NMDA receptor antagonist.
Shoaib M; Schindler CW; Goldberg SR; Pauly JR
Psychopharmacology (Berl); 1997 Nov; 134(2):121-30. PubMed ID: 9399375
[TBL] [Abstract][Full Text] [Related]
20. Pre- and postsynaptic dopamine mechanisms after repeated nicotine: effects of adrenalectomy.
Molander A; Söderpalm B
Eur J Pharmacol; 2003 Nov; 481(1):51-8. PubMed ID: 14637174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
